Study details
Enrolling now
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
The University of Texas Health Science Center at San Antonio
NCT IDNCT06108076ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
10
Study length
about 2 years
Ages
18–80
Locations
1 site in TX
About this study
Researchers are testing whether oral ketones can affect heart function in people with heart failure, reduced ejection fraction, and type 2 diabetes. The trial will last for about a year and a half.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Ketone Monoester (KE)
PhaseEARLY_Phase 1
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Glucose, Patient Reported Outcomes Measure Information System (PROMIS) - Physical Function, Six minute walk test
Body systems
Endocrinology, Cardiology / Heart